Ocrelizumab in Breastmilk

Clinical trial NCT04387110 · COMPLETED

Trial details

NCT number: NCT04387110
Sponsor: University of California, San Francisco
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis Clinically Isolated Syndrome

Start date: 2020-08-07
Primary completion: 2022-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.